UnknownNot Applicable

Accuracy of Assessing the Gingival Biotype in Upper Anterior in Adult Patients, Using Different Methods.

Egypt63 participantsStarted 2020-11-01

Plain-language summary

The study is a Diagnostic accuracy study that determining the accuracy of assessing the gingival biotype and some other anatomic parameters,including (crown width / crown length ratio, attached gingival width, labial bone thickness and papilla volume) by different methods :1- probe transparency, 2-transgingival probing, 3-cone beam computed tomography, 4-intraoral digital scanning, 5-extraoral digital scanning

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male and female Patients whose age is between 18 to 40 years old.
✓. Health teeth only will be included.
✓. Patients who already need esthetic rehabilitation treatment (implant placement, restorative treatments, periodontal therapy, and root coverage) on anterior maxilla and this treatment needs to investigate the gingival biotype.
✓. An un-inflamed periodontal condition with a periodontal probing depth of no more than 3 mm, a bleeding index of \< 2, and no gingival recession on maxillary anterior teeth.
✓. Provide informed consent.

Exclusion criteria

✕. Pregnant or lactating females.
✕. Restoration or crowns in the maxillary anterior dentition.
✕. Malocclusion.
✕. Use of any medication affecting the soft tissue.
✕. Cigarette smoking.
✕. Individuals with chronic systemic diseases such as diabetes, endocrine and haematological pathologies.
✕. Patients having problem in opening their mouth or undergoing inter-maxillary fixation where oral examination will not be possible.
✕. Patients diagnosed with psychiatric problems or intoxicated with alcohol or drugs.

What they're measuring

gingival biotype assessment by different methods.

Timeframe: the outcome measure will be assessed and for which data will be reported up to 24 weeks"

Trial details

NCT IDNCT04640506

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-07

View on ClinicalTrials.gov More Periodontal Diseases trials